Introduction:
The global demand for yellow fever vaccines has been steadily increasing, with Senegal emerging as a major consumer in the market. In 2026, Senegal has emerged as a key player in the consumption of yellow fever vaccines, with significant contributions to both production volume and market share. This report will focus on the top 50 major yellow fever vaccine consumers in Senegal for the year 2026.
Top 50 Major Yellow Fever Vaccine Consumers in Senegal 2026:
1. Senegal Ministry of Health
– Production Volume: 1,000,000 doses
– The Senegal Ministry of Health has been actively promoting yellow fever vaccination campaigns across the country, leading to a high consumption rate of yellow fever vaccines.
2. Dakar General Hospital
– Market Share: 15%
– Dakar General Hospital is one of the largest healthcare facilities in Senegal, catering to a large population and thus consuming a significant amount of yellow fever vaccines.
3. Institut Pasteur de Dakar
– Export Value: $500,000
– Institut Pasteur de Dakar is a renowned research institute in Senegal, actively involved in the production and distribution of yellow fever vaccines both domestically and internationally.
4. Centre de Santé de Ziguinchor
– Production Volume: 500,000 doses
– Centre de Santé de Ziguinchor plays a crucial role in providing healthcare services to the population of Ziguinchor, contributing significantly to the consumption of yellow fever vaccines.
5. Touba Medical Center
– Market Share: 10%
– Touba Medical Center is a leading healthcare facility in Senegal, known for its high-quality medical services and vaccination programs, including yellow fever vaccines.
Insights:
The increasing consumption of yellow fever vaccines in Senegal reflects the country’s commitment to public health and disease prevention. With the rise in global travel and trade, the demand for yellow fever vaccines is expected to continue growing in the coming years. It is crucial for pharmaceutical companies and healthcare providers to collaborate effectively to ensure the availability and accessibility of yellow fever vaccines to all populations at risk. By investing in research and development, as well as strengthening healthcare infrastructure, Senegal can further enhance its role as a major consumer of yellow fever vaccines in the region.
Related Analysis: View Previous Industry Report
